Clinical Trials Logo

Filter by:
NCT ID: NCT00159887 Completed - Clinical trials for Pulmonary Hypertension

Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

Start date: December 2002
Phase: Phase 3
Study type: Interventional

Open label extension study to the pivotal efficacy study to assess the safety of sildenafil citrate in patients with pulmonary arterial hypertension

NCT ID: NCT00159861 Completed - Clinical trials for Pulmonary Hypertension

The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH

Start date: July 2003
Phase: Phase 3
Study type: Interventional

Determination of the effects of sildenafil citrate and epoprostenol when used in combination in patients with pulmonary arterial hypertension

NCT ID: NCT00159835 Completed - Clinical trials for Cardiovascular Diseases

Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD

IDEAL
Start date: February 1999
Phase: Phase 4
Study type: Interventional

To investigate whether a long-term strategy to lower LDL cholesterol with atorvastatin as much as possible will improve prognosis in CHD patients compared with a strategy reflecting current best clinical practice with simvastatin.

NCT ID: NCT00159770 Completed - Schizophrenia Clinical Trials

Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

Start date: November 2001
Phase: Phase 3
Study type: Interventional

Evaluation of the antipsychotic efficacy and safety of ziprasidone versus olanzapine, risperidone or quetiapine in patients with schizophrenia, schizoaffective and schizophreniform disorders under naturalistic conditions of clinical practice

NCT ID: NCT00159497 Completed - Coxarthrosis Clinical Trials

Bone Remodeling Around HA-coated Acetabular Cups.

Start date: October 1998
Phase: Phase 4
Study type: Interventional

This study was designed to investigate the influence of HA-coating on bone remodeling around the cup in cementless THA. 100 patients gave informed consent to participate in a controlled randomized study between porous coated Trilogy® versus Trilogy Calcicoat®. The cup was inserted in press-fit fixation. The femoral component was a cementless porous coated titanium alloy stem (Bi-Metric®), with a modular 28 mm CrCo head. Effect parameters were Harris Hip Score (HHS) and Bone Mineral Density (BMD) determined by DEXA scanning. Measurements revealed no difference between the two groups after 3 years, neither in clinical outcome nor in terms of periprosthetic bone density. Patients with Body Mass Index above normal regained more bone mineral than patients with normal weight. This finding supports the assumption that load is beneficial to bone remodeling. Advantages of better sealing of the bone-prosthesis interface, preventing polyethylene induced osteolysis, may still be anticipated for the 7 or 12 year follow-up examinations

NCT ID: NCT00159185 Completed - Quality of Life Clinical Trials

Epidemiology Study in Major Orthopaedic Surgery

Start date: January 2004
Phase: N/A
Study type: Observational

The purpose of this study is to: - Create a database including a description of the patient population that undergoes total hip replacement with special emphasis on orthopedic and cardiovascular complications and the quality of life 1 year postoperatively. - Characterise the patient at risk for the above mentioned events - Create methods for predicting patients at risk for short-term (90 days) and long term (1 year) complications in relation to hip replacement surgery.

NCT ID: NCT00158899 Completed - Dyslipidaemia Clinical Trials

GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol

Start date: August 2004
Phase: Phase 2
Study type: Interventional

The purpose of this clinical research study is to compare up to 3 doses of an investigational drug GW501516 to placebo (an inactive pill that looks like GW501516) to see if it is safe, well tolerated and effective in improving (raising) low levels of "good cholesterol", high-density lipoprotein cholesterol (HDLc), as compared to placebo.

NCT ID: NCT00156897 Completed - Obesity Clinical Trials

Efficacy and Safety of ATL-962 in Obese Diabetics

Start date: December 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate whether ATL-962 induces weight loss in diabetic patients and whether its safety and tolerability profile is superior to that of orlistat in such patients

NCT ID: NCT00155961 Completed - Metabolic Syndrome Clinical Trials

Odense Androgen Study in the Elderly

Start date: March 2002
Phase: Phase 1
Study type: Observational

Introduction Male ageing is associated with sarcopenia, frailty, osteopenia, obesity, the metabolic syndrome and cardiovascular disease. To what extent the androgens affect these signs of ageing is still largely undetermined. A few studies have shown divergent results concerning the relation between ageing and serum levels of testosterone. It still remains to be shown whether there is a pure age-related decline in serum testosterone or whether other factors such as obesity, chronic illness or medication are responsible for the lower serum testosterone found in elderly men when compared with young men. To investigate these issues a cohort of 600 men aged 60 to 75 years is examined. Objective The aim of the study is to investigate the relation of testosterone (T) to body composition (BC) and physical performance (PP). Measures for BC are muscle mass (MM), bone mineral density (BMD) and fat mass (FM). Parameters for PP are maximum voluntary force (MVF), maximum oxygen uptake (VO2max) and muscle power (P). We hypothesize that T is positively associated with MM, BMD and all PP parameters, but negatively associated with FM. We will furthermore examine whether life style, medication, chronic disease, hormones and binding proteins exert their actions on BC and PP solely through or independently of T. The levels of s-total and free T in this cohort will be compared with the s-total and free T levels from a cohort of young men aged 20 to 30 years. Furthermore the associations found between T and BC and PP in the two cohorts will be compared to investigate whether T plays the same role in the two groups.

NCT ID: NCT00154492 Completed - Cirrhosis Clinical Trials

Use of NovoSeven® in Active Variceal Bleeding

Start date: April 2004
Phase: Phase 2
Study type: Interventional

This trial is conducted in Asia and Europe. The trial is planned to investigate the effectiveness and safety of NovoSeven® in patients with advanced cirrhosis and active variceal bleeding.